Biography: Life Sciences

Jeffrey S Rothstein leads Sidley's global technology transactions practice team. His practice covers a wide range of technology and corporate transactions, with particular emphasis on pharmaceutical, biotechnology and information technology matters. His biotech experience includes both human and agricultural biotechnology. He has been selected as one of the world's leading patent and technology licensing lawyers in IAM Licensing 250: The World's Leading Patent and Technology Licensing Practitioners, and has been recognised as a leading lawyer by Chambers USA and PLC Which Lawyer.

Mr Rothstein advises firms ranging from early-stage companies to the world's leading biotechnology and pharmaceutical companies on licensing, development, collaboration, contract manufacturing, clinical trial, contract research and other similar agreements. He also handles intellectual property issues arising in life sciences M&A and joint venture transactions. Representative life sciences clients include F Hoffman-La Roche Ltd, Monsanto Company and GE Healthcare.

Mr Rothstein lectures annually at Northwestern University on e-commerce and bankruptcy law and has spoken on patent cross-licensing from a practitioner's perspective at the Berkeley Center for Law and Technology. Most recently, he spoke on "Alternative Pathways and Partnerships to Facilitate Funding Drug Discovery and Development" at the American Conference Institute's advanced forum on life sciences collaborative agreements and acquisitions. He is a trustee of the Adler Planetarium and Astronomy Museum.

Mr Rothstein received his JD from the University of Chicago Law School in 1982 and his AB from Harvard College in 1978. He is admitted in Illinois.